Extending the term of exclusive access to clinical trial data will raise drug costs in the short term but also help approve 200 extra drugs and result in greater life expectancy in the long term, ...
NEW YORK, Dec 4 (Reuters) - Global drugmaker Pfizer Inc will broaden access to information from its scores of clinical trials to independent researchers and to patients who take part in the studies, ...
Revolutionary AI assistant RISA eliminates the pain of hunting for patient data across multiple systems, enabling clinicians to focus more on patient care ThetaRho.ai, a provider of AI-powered ...
New data shows that China and the US dominate breast cancer clinical trial expertise while lower-income countries remain ...
New functionality within Counterpart Assistant uses Google Cloud’s Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data WILMINGTON, Del., March 03, ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Zacks Investment Research on MSN
GPCR stock soars 102% on strong phase II obesity data for Aleniglipron
Shares of Structure Therapeutics GPCR skyrocketed 102.5% after the company reported positive top-line data from the ACCESS ...
Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback